METHODS	We performed a placebo-controlled pilot trial to evaluate the safety of celecoxib in patients with ulcerative colitis in remission who had a present or past history of nonspecific arthritis , arthralgia , or other condition amenable to nonsteroidal anti-inflammatory drug therapy .\